<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04222569</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL19_0197</org_study_id>
    <nct_id>NCT04222569</nct_id>
  </id_info>
  <brief_title>Determination of the Optimal Spontaneous Breathing Trial During Weaning of Mechanical Ventilation</brief_title>
  <acronym>GLOBAL WEAN</acronym>
  <official_title>Determination of the Optimal Spontaneous Breathing Trial During Weaning of Mechanical Ventilation: a Randomized and Personalized Cross Over Physiologic Study in the Perioperative and Critically Ill Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment and comparison of three spontaneous breathing trials in five specific profiles of&#xD;
      intensive care unit and perioperative patients. A physiological cross over study&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Mechanical ventilation is the most used organ replacement therapy in intensive care unit&#xD;
      (ICU). After resolution of acute illness, separating the ventilator from the patient may be&#xD;
      specially challenging. Before extubation, it is recommended to perform a spontaneous&#xD;
      breathing trial (SBT) to evaluate the ability to sustain breathing with minimal or no&#xD;
      support.&#xD;
&#xD;
      The way to carry out this step of the weaning process present important variation across&#xD;
      regions of the world. Two techniques are preferentially used : the T-piece trial (oxygen&#xD;
      supply without positive pressure) and low pressure support ventilation (PSV) from 6 to 10&#xD;
      cmH2O according to the airway humidification device.&#xD;
&#xD;
      The best strategy for successful weaning remains unknow, especially about specific subgroups&#xD;
      of respiratory and neurological diseases.&#xD;
&#xD;
      Our aim is to assess which spontaneous breathing trial would best reproduce post-extubation&#xD;
      inspiratory effort. We compare T-piece trial, PSV 7 cmH2O without positive end expiratory&#xD;
      pressure (PEEP) and PSV 0 cmH2O without PEEP. Five specific profiles are evaluated : chronic&#xD;
      obstructive pulmonary disease (COPD), severe brain injury, blunt thoracic trauma, post&#xD;
      abdominal surgery and miscellaneous.&#xD;
&#xD;
      The hypothesis is that T-piece trial and PSV 0 CPAP 0 trial are the best for mimic&#xD;
      inspiratory effort after extubation. However, we could highlight various results according to&#xD;
      different subgroups of ICU patients. The final aim is to determine a personalized wean trial&#xD;
      for each.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Each patient, serving as their own control, realize three SBT for 15 minutes: T-piece, PSV 7 cmH2O without PEEP and PSV 0 cmH2O without PEEP. The order is randomized. The randomization is stratified on pathology. For avoid a carry-over effect, a wash-out period of baseline ventilation for 10 minutes will be respected between trials. The humidification device is a heated humidifier, linked to the ventilator. Data are recorded before (guarantee of real return to baseline) and after each SBT.&#xD;
Then, extubation is decided by clinician in charge, in accordance with guidelines. A 30 min of resting period is respected before. Data are recorded before and 20 minutes after extubation.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Esophageal Pressure Time Product (PTPes)</measure>
    <time_frame>Immediately before each spontaneous breath trial</time_frame>
    <description>Reliable assessment of patient's inspiratory effort. This variable is calculated by integration of esophageal pressure over time, measured with esophageal manometric catheter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Esophageal Pressure Time Product (PTPes)</measure>
    <time_frame>Immediately after each spontaneous breath trial</time_frame>
    <description>Reliable assessment of patient's inspiratory effort. This variable is calculated by integration of esophageal pressure over time, measured with esophageal manometric catheter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Esophageal Pressure Time Product (PTPes)</measure>
    <time_frame>Immediately before extubation</time_frame>
    <description>Reliable assessment of patient's inspiratory effort. This variable is calculated by integration of esophageal pressure over time, measured with esophageal manometric catheter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Esophageal Pressure Time Product (PTPes)</measure>
    <time_frame>20 minutes after extubation</time_frame>
    <description>Reliable assessment of patient's inspiratory effort. This variable is calculated by integration of esophageal pressure over time, measured with esophageal manometric catheter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective discomfort assessment with Numeric discomfort scale</measure>
    <time_frame>Immediately before each spontaneous breath trial</time_frame>
    <description>visual numeric scale from 0 (no discomfort) to 10 (worst discomfort experienced)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective discomfort assessment with Numeric discomfort scale</measure>
    <time_frame>Immediately after each spontaneous breath trial</time_frame>
    <description>visual numeric scale from 0 (no discomfort) to 10 (worst discomfort experienced)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective discomfort assessment with respiratory rate &gt; 30 bpm</measure>
    <time_frame>Immediately before each spontaneous breath trial</time_frame>
    <description>Respiratory rate &gt; 30 bpm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective discomfort assessment with respiratory rate &gt; 30 bpm</measure>
    <time_frame>Immediately after each spontaneous breath trial</time_frame>
    <description>Respiratory rate &gt; 30 bpm</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Esophageal Pressure Time Product (PTPes)</measure>
    <time_frame>24 hours after extubation</time_frame>
    <description>If esophageal manometer still in place, patient's inspiratory effort long time after extubation (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Esophageal Pressure Time Product (PTPes)</measure>
    <time_frame>48 hours after extubation</time_frame>
    <description>If esophageal manometer still in place, patient's inspiratory effort long time after extubation (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Tidal impedance variation (TIV) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately before each spontaneous breath trial</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Tidal impedance variation (TIV) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately after each spontaneous breath trial</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Tidal impedance variation (TIV) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately before extubation</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Tidal impedance variation (TIV) assessed with Electrical Impedance Tomography</measure>
    <time_frame>20 minutes after extubation</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>End Expiratory Lung Impedance (EELZ) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately before each spontaneous breath trial</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>End Expiratory Lung Impedance (EELZ) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately after each spontaneous breath trial</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>End Expiratory Lung Impedance (EELZ) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately before extubation</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>End Expiratory Lung Impedance (EELZ) assessed with Electrical Impedance Tomography</measure>
    <time_frame>20 minutes after extubation</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Global inhomogeneity index (GI) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately before each spontaneous breath trial</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Global inhomogeneity index (GI) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately after each spontaneous breath trial</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Global inhomogeneity index (GI) assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately before and after extubation</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Global inhomogeneity index (GI) assessed with Electrical Impedance Tomography</measure>
    <time_frame>20 minutes after extubation</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Regional Ventilation Delay (RVD) index assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately before each spontaneous breath trial</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Regional Ventilation Delay (RVD) index assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately after each spontaneous breath trial</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Regional Ventilation Delay (RVD) index assessed with Electrical Impedance Tomography</measure>
    <time_frame>Immediately before extubation</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <other_outcome>
    <measure>Regional Ventilation Delay (RVD) index assessed with Electrical Impedance Tomography</measure>
    <time_frame>20 minutes after extubation</time_frame>
    <description>Assessment of pulmonary volumes, only for the patients included in the center of Saint Eloi University hospital (ancillary study)</description>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Intensive Care Unit</condition>
  <condition>Invasive Mechanical Ventilation</condition>
  <condition>Ready to Wean From Ventilation</condition>
  <arm_group>
    <arm_group_label>T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First T-piece trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First T-piece trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piece</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min. After 10 min of rest, PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piece</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>First PSV 7 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, PSV 0 cmH2O and PEEP 0 cmH2O trial for 15 min. After 10 min of rest, T-piece trial for 15 min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>T-piece</intervention_name>
    <description>Spontaneous breath trial with a T-piece</description>
    <arm_group_label>PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piece</arm_group_label>
    <arm_group_label>PSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0</arm_group_label>
    <arm_group_label>PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piece</arm_group_label>
    <arm_group_label>PSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0</arm_group_label>
    <arm_group_label>T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0</arm_group_label>
    <arm_group_label>T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PSV 7 and PEEP 0</intervention_name>
    <description>Spontaneous breath trial with a pressure support ventilation of 7 cmH2O and no positive end expiratory pressure</description>
    <arm_group_label>PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piece</arm_group_label>
    <arm_group_label>PSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0</arm_group_label>
    <arm_group_label>PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piece</arm_group_label>
    <arm_group_label>PSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0</arm_group_label>
    <arm_group_label>T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0</arm_group_label>
    <arm_group_label>T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PSV 0 and PEEP 0</intervention_name>
    <description>Spontaneous breath trial without pressure support ventilation and positive end expiratory pressure, with a patient intubated and connected to the ventilator</description>
    <arm_group_label>PSV 0 PEEP 0 and PSV 7 PEEP 0 and T-piece</arm_group_label>
    <arm_group_label>PSV 0 PEEP 0 and T-piece and PSV 7 PEEP 0</arm_group_label>
    <arm_group_label>PSV 7 PEEP 0 and PSV 0 PEEP 0 and T-piece</arm_group_label>
    <arm_group_label>PSV 7 PEEP 0 and T-piece and PSV 0 PEEP 0</arm_group_label>
    <arm_group_label>T-piece and PSV 0 PEEP 0 and PSV 7 PEEP 0</arm_group_label>
    <arm_group_label>T-piece and PSV 7 PEEP 0 and PSV 0 PEEP 0</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ICU patient with invasive mechanical ventilation for at least 24 hours&#xD;
&#xD;
          -  Physician decision to extubate and all criteria for ventilatory weaning must be&#xD;
             present&#xD;
&#xD;
          -  Resolution of disease acute phase for which the patient was intubated&#xD;
&#xD;
          -  Conscious patient (Richmond Agitation-Sedation Scale (RASS) &gt; 0), no sedation&#xD;
&#xD;
          -  Good coughing effort, good swallowing, positive leak test (&gt; 12% of tidal volume (VT))&#xD;
&#xD;
          -  No important secretions&#xD;
&#xD;
          -  No respiratory acidosis, adequate oxygenation (PaO2 / FiO2 &gt; 150 mmHg and CPAP ≤ 8)&#xD;
&#xD;
          -  Adequate pulmonary function (respiratory rate (RR) ≤ 35, negative inspiratory force&#xD;
             (NIF) &gt; 20 cmH2O, RR/VT &lt; 105)&#xD;
&#xD;
          -  Stable cardiovascular status (heart rate (HR) &lt; 140 bpm, systolic blood pressure &gt; 90&#xD;
             mmHg, no or minimal vasopressors)&#xD;
&#xD;
          -  If severe brain injury, the VISAGE score must be ≥ 3 (visual pursuit, good swallowing,&#xD;
             GCS &gt; 10)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Obese patients with BMI ≥ 35 kg/m2&#xD;
&#xD;
          -  Contraindication for nasogastric tube or esophageal manometric balloon placement&#xD;
&#xD;
          -  Refusal of study participation or to pursue the study by the patient, no consent&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Absence of coverage by the French statutory healthcare insurance system&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samir Jaber, MD, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Montpellier University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Audrey De Jong, MD, PHD</last_name>
    <phone>0033467337271</phone>
    <email>a-de_jong@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samir Jaber, MD, PHD</last_name>
    <phone>0033467337271</phone>
    <email>s-jaber@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Saint Eloi</name>
      <address>
        <city>Montpellier</city>
        <state>Herault</state>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samir Jaber, MD, PHD</last_name>
      <phone>0033467337271</phone>
      <email>s-jaber@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Audrey De Jong, MD, PHD</last_name>
      <phone>0033467337271</phone>
      <email>a-de_jong@chu-montpellier.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Samir Jaber, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Audrey De Jong, MD, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gerald Chanques, MD, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mathieu Capdevila</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Mahul M, Jung B, Galia F, Molinari N, de Jong A, Coisel Y, Vaschetto R, Matecki S, Chanques G, Brochard L, Jaber S. Spontaneous breathing trial and post-extubation work of breathing in morbidly obese critically ill patients. Crit Care. 2016 Oct 27;20(1):346.</citation>
    <PMID>27784322</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 10, 2020</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Intensive Care Unit</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Mechanical Ventilation Weaning</keyword>
  <keyword>Spontaneous Breath Trial</keyword>
  <keyword>Rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual patient data will be made available upon a reasonable request</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>12 months after the main publication</ipd_time_frame>
    <ipd_access_criteria>Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and institutional review board (IRB) review. Dataset will be shared after careful examination by the study board of investigators.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

